TREATMENT
Real-world study of 549 Spanish patients evaluates trifluridine/tipiracil plus bevacizumabA multicenter study across 19 Spanish hospitals evaluated real-world effectiveness and safety of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer after at least two prior treatment regimens. (ESMO Gastrointestinal Oncology)